Sinus lift with autologous bone alone or in addition to equine bone: An immunohistochemical study in man

Implant Dentistry

Volumn 20, Issue 5, 2011, Pages 383-388

  Artese, Luciano ^a   Piattelli, Adriano ^a   Di Stefano, Danilo Alessio ^b   Piccirilli, Marcello ^a   Pagnutti, Stefano ^a   D'Alimonte, Emanuela ^a   Perrotti, Vittoria ^a  

^a UNIVERSITY OF CHIETI   (Italy)

^b NONE

Author keywords

autologous bone; bone regeneration; equine bone; immunohistochemistry; sinus augmentation procedures

Indexed keywords

BIOMATERIAL; CD31 ANTIGEN; COLLAGEN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; NEURONAL NITRIC OXIDE SYNTHASE; NOS1 PROTEIN, HUMAN; NOS3 PROTEIN, HUMAN; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ADULT; AGED; ANIMAL; ARTICLE; ARTIFICIAL MEMBRANE; AUTOTRANSPLANTATION; BONE DEVELOPMENT; BONE TRANSPLANTATION; COMPARATIVE STUDY; EDENTULOUSNESS; FEMALE; HORSE; HUMAN; IMAGE PROCESSING; IMMUNOHISTOCHEMISTRY; MALE; MAXILLA; METHODOLOGY; MICROVASCULATURE; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; PLASTIC SURGERY; SINUS FLOOR AUGMENTATION; VIDEO MICROSCOPY; XENOGRAFT;

ADULT; AGED; ANIMALS; ANTIGENS, CD31; BIOCOMPATIBLE MATERIALS; BONE TRANSPLANTATION; COLLAGEN; FEMALE; HORSES; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; JAW, EDENTULOUS, PARTIALLY; MALE; MAXILLA; MEMBRANES, ARTIFICIAL; MICROSCOPY, VIDEO; MICROVESSELS; MIDDLE AGED; NITRIC OXIDE SYNTHASE TYPE I; NITRIC OXIDE SYNTHASE TYPE III; OSTEOGENESIS; SINUS FLOOR AUGMENTATION; SURGICAL FLAPS; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HETEROLOGOUS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 80053561165     PISSN: 10566163     EISSN: None     Source Type: Journal    
DOI: 10.1097/ID.0b013e3182310b3d     Document Type: Article

References (45)

1. Furst G, Gruber R, Tangl S, et al. Sinus grafting with autogenous plateletrich plasma and bovine hydroxyapatite. A histomorphometric study in minipigs. Clin Oral Implants Res. 2003;14:500-508. (Pubitemid 37485606)
2. Lioubavina-Hack N, Lang NP, Karring T. Significance of primary stability for osseointegration of dental implants. Clin Oral Implants Res. 2006;17:244-250. (Pubitemid 43709390)
3. Hallman M, Lederlund A, Linsskog S, et al. A clinical histologic study of bovine hydroxyapatite in combination with autogenous bone and fibrin glue for maxillary sinus floor augmentation. Results after 8 months of healing. Clin Oral Implants Res. 2001;12:135-143. (Pubitemid 33723238)
4. Wang M. Developing bioactive composite materials for tissue replacement. Biomaterials. 2003;24:2133-2151. (Pubitemid 36434032)
5. Yildirim M, Spiekermann H, Biesterfeld S, et al. Maxillary sinus augmentation using xenogenic bone substitute material Bio-Oss in combination with venous blood. A histologic and histomorphometric study in humans. Clin Oral Implants Res. 2000;11:217-229.
6. Traini T, Valentini P, Iezzi G, et al. A histologic and histomorphometric evaluation of anorganic bovine bone retrieved 9 years after a sinus augmentation procedure. J Periodontol. 2007;78:955-961.
7. Lee DW, Pi SH, Lee SK, et al. Comparative histomorphometric analysis of extraction sockets healing implanted with bovine xenografts, irradiated cancellous allografts, and solvent-dehydrated allografts in humans. Int J Oral Maxillofac Implants. 2009;24:609-615.
8. Crespi R, Capparè P, Gherlone E. Dental implants placed in extraction sites grafted with different bone substitutes: Radiographic evaluation at 24 months. J Periodontol. 2009;80:1616-1621.
9. Maiorana C, Sicurtà D, Mirandola A, et al. Sinus elevation with alloplasts or xenogenic materials and implants: An up-to 4-year clinical and radiologic follow-up. Int J Oral Maxillofac Implants. 2006;21:426-432. (Pubitemid 43962668)
10. Barone A, Crespi R, Aldini NN, et al. Maxillary sinus augmentation: Histologic and histomorphometric analysis. Int J Oral Maxillofac Implants. 2005;20:519-525. (Pubitemid 41549218)
11. Orsini G, Scarano A, Piattelli M, et al. Histologic and ultrastructural analysis of regenerated bone in maxillary sinus augmentation using a porcine bone-derived biomaterial. J Periodontol. 2006;77:1984-1990. (Pubitemid 46002077)
12. El-Sabban ME, El-Khoury H, Hamdan-Khalil R, et al. Xenogenic bone matrix extracts induce osteoblastic differentiation of human bone marrow-derived mesenchymal stem cells. Regen Med. 2007;2:383-390. (Pubitemid 47304958)
13. Li H, Springer M, Zou X, et al. Ectopic bone induction by equine bone protein extract. Adv Exp Med Biol. 2006;585: 393-402.
14. Perrotti V, Nicholls BM, Piattelli A. Human osteoclast formation and activity on an equine spongy bone substitute. Clin Oral Implants Res. 2009;20:17-23.
15. Di Stefano DA, Artese L, Iezzi G, et al. Alveolar ridge regeneration with equine spongy bone: A clinical, histological, and immunohistochemical case series. Clin Implant Dent Relat Res. 2009;11:90-100.
16. Merkx MA, Maltha JC, Freihofer HP, et al. Incorporation of particulated bone implants in the facial skeleton. Biomaterials. 1999;20:2029-2035. (Pubitemid 29447624)
17. Lakey LA, Akella R, Ranieri JP. Angiogenesis: Implications for tissue repair. In: Davies JE. Bone Engineering. Em Squared Incorporated: Toronto, Canada; 2000:137-142.
18. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other diseases. Nat Med. 1995;1:27-31.
19. Kohno S, Kaku M, Tsutsui K, et al. Expression of vascular endothelial growth factor and the effects on bone remodelling during experimental tooth movement. J Dent Res. 2003;82:177-182. (Pubitemid 41766039)
20. Yoshino H, Morita I, Murota SI, et al. Mechanical stress induces production of angiogenic regulators in cultured human gingival and periodontal ligament fibroblasts. J Periodontal Res. 2003;38:405-410. (Pubitemid 37465548)
21. Carano RA, Filvaroff EH. Angiogenesis and bone repair. Drug Discov Today. 2003;8:980-989. (Pubitemid 37474243)
22. Collin-Osdoby P, Nickols GA, Osdoby P. Bone cell function, regulation, and communication: A role for nitric oxide. J Cell Biochem. 1995;57:399-408.
23. Palmer RM, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 1987;327:524-526. (Pubitemid 17085822)
24. Paakkari I, Lindsberg P. Nitric oxide in the central nervous system. Ann Med. 1995;27:369-377.
25. Prast H, Philippu A. Nitric oxide as modulator of neuronal function. Prog Neurobiol. 2001;64:51-68. (Pubitemid 32201889)
26. Mellion BT, Ignarro LJ, Myers CB, et al. Inhibition of human platelet aggregation by S-nitrosothiols. Heme-dependent activation of soluble guanylate cyclase and stimulation of cyclic GMP accumulation. Mol Pharmacol. 1983;23:653-664. (Pubitemid 13089783)
27. Moncada S, Palmer RM, Higgs E. Nitric oxide: Physiology, pathophysiology and pharmacology. Pharmacol Rev. 1991; 43:109-142.
28. Brennan PA, Thomas GJ, Langdon JD. The role of nitric oxide in oral diseases. Arch Oral Biol. 2003;48:93-100. (Pubitemid 36453660)
29. Connelly ST, Macabeo-Ong M, Dekker N, et al. Increased nitric oxide levels and iNOS over-expression in oral squamous cell carcinoma. Oral Oncol. 2005;41: 261-262.
30. Shang ZJ, Li JR. Expression of endothelial nitric oxide synthase and vascular endothelial growth factor in oral squamous cell carcinoma: Its correlation with angiogenesis and disease progression. J Oral Pathol Med. 2005;34:134-139. (Pubitemid 40293221)
31. Cawood JI, Howell RA. A classification of the edentulous jaws. Int J Oral Maxillofac Surg. 1988;17:232-236.
32. Duda DG, Cohen KS, Scadden DT, et al. A protocol for phenotypic detection and enumeration of circulating endothelial cells and circulating progenitor cells in human blood. Nat Protoc. 2007;2:805-810. (Pubitemid 46745577)
33. Yamada Y, Tamura T, Hariu K, et al. Angiogenesis in newly augmented bone observed in rabbit calvarium using a titanium cap. Clin Oral Implants Res. 2008;19: 1003-1009.
34. Galindo-Moreno P, Padial-Molina M, Fernandez-Barbero EJ, et al. Optimal microvessel density from composite graft of autogenous maxillary cortical bone and anorganic bovine bone in sinus augmentation: Influence of clinical variations. Clin Oral Implants Res. 2010;21:221-227.
35. Kanczler JM, Oreffo RO. Osteogenesis and angiogenesis: The potential for engineering bone. Eur Cells Mater. 2008;15:100-114. (Pubitemid 351955734)
36. Costa C, Soares R, Schmitt F. Angiogenesis: Now and then. APMIS. 2004;112:402-412. (Pubitemid 39642170)
37. De Marco AC, Jardini MA, Lima LP. Revascularization of autogenous block grafts with or without an e-PTFE membrane. Int J Oral Maxillofac Implants. 2005; 20:867-874. (Pubitemid 43104464)
38. Degidi M, Artese L, Rubini C, et al. Microvessel density in sinus augmentation procedures using anorganic bovine bone and autologous bone: 3 months results. Implant Dent. 2007;16:317-325.
39. Huang YC, Kaigler D, Rice KG, et al. Combined angiogenic and osteogenic factor delivery enhances bone marrow stromal cell-driven bone regeneration. J Bone Miner Res. 2005;20:848-857. (Pubitemid 40571642)
40. Degidi M, Artese L, Rubini C, et al. Microvessel density and vascular endothelial growth factor expression in sinus augmentation using Bio-Oss. Oral Dis. 2006; 12:469-475. (Pubitemid 44252539)
41. Boeck-Neto RJ, Artese L, Piattelli A, et al. VEGF and MVD expression in sinus augmentation with autologous bone and several graft materials. Oral Dis. 2009;15: 148-154.
42. Schlegel KA, Fichtner G, Schultze-Mosgau S, et al. Histological findings in sinus augmentation with autogenous bone chips versus a bovine bone substitute. Int J Oral Maxillofac Implants. 2003;18:53-58. (Pubitemid 37140453)
43. Pjetursson BE, Tan WC, Zwahlen M, et al. A systematic review of the success of sinus floor elevation and survival of implants inserted in combination with sinus floor elevation. J Clin Periodontol. 2008; 35(8 suppl):216-240.
44. Schlegel KA, Zimmermann R, Thorwarth M, et al. Sinus floor elevation using autogenous bone or bone substitute combined with platelet-rich plasma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007;104:e15-e25.
45. Stievano D, Di Stefano A, Ludovichetti M, et al. Maxillary sinus lift through heterologous bone grafts and simultaneous acid-etched implants placement. Five-year follow-up. Minerva Chir. 2008; 63:79-91.